These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9652680)

  • 1. COX provides missing link in mechanism of aspirin in colon cancer.
    Wunsch H
    Lancet; 1998 Jun; 351(9119):1864. PubMed ID: 9652680
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin and salicylate: An old remedy with a new twist.
    Wu KK
    Circulation; 2000 Oct; 102(17):2022-3. PubMed ID: 11044413
    [No Abstract]   [Full Text] [Related]  

  • 3. Cox-2-selective inhibitors: the new super aspirins.
    DeWitt DL
    Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective cyclooxygenase-2 inhibition: biological and clinical effects.
    Conti F; Spinelli FR; Ossandon A; Valesini G
    Isr Med Assoc J; 2000 Nov; 2(11):841-7. PubMed ID: 11344755
    [No Abstract]   [Full Text] [Related]  

  • 5. COX-2 inhibitors--is there cause for concern?
    Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
    Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
    [No Abstract]   [Full Text] [Related]  

  • 6. Non steroidal anti-inflammatory drugs, cyclooxygenase selectivity and gastrointestinal toxicity.
    Jacob M; Simpson R; Bjarnason I
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):12-8. PubMed ID: 9615258
    [No Abstract]   [Full Text] [Related]  

  • 7. Review article: cyclooxygenase--a target for colon cancer prevention.
    Dubois RN
    Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():64-7. PubMed ID: 10807405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Colon cancer and COX-2].
    Ota S; Bamba H; Imai Y; Arai S; Fujiwara K
    Nihon Shokakibyo Gakkai Zasshi; 2002 Mar; 99(3):253-63. PubMed ID: 11925862
    [No Abstract]   [Full Text] [Related]  

  • 9. The discovery and function of COX-2.
    Needleman P; Isakson PC
    J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
    [No Abstract]   [Full Text] [Related]  

  • 10. [Is it safe and efficient to use nonsteroidal anti-inflammatory agent by selective reduction of prostaglandin production?].
    Kankaanranta H; Vapaatalo H
    Duodecim; 1996; 112(5):419-24. PubMed ID: 10592604
    [No Abstract]   [Full Text] [Related]  

  • 11. COX-1 and COX-2 inhibition: current status and future perspective.
    Greyn J; Lauwers MH; Vanlersberghe C; Camu F
    Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
    [No Abstract]   [Full Text] [Related]  

  • 12. [New NSAIDS: COX-1, COX-2, what about them?].
    Peretz A
    Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats].
    Laudanno OM; Cesolari JA; Esnarriaga J; Flaherty P; Vada J; Guastalli G; San Miguel P; Bedini OA
    Acta Gastroenterol Latinoam; 1998; 28(3):249-55. PubMed ID: 9773153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular perspective: cyclooxygenase-2.
    Goodsell DS
    Stem Cells; 2000; 18(3):227-9. PubMed ID: 10840077
    [No Abstract]   [Full Text] [Related]  

  • 15. New perspectives for nonsteroidal antiinflammatory therapy.
    de Brum-Fernandes AJ
    J Rheumatol; 1997 Feb; 24(2):246-8. PubMed ID: 9034978
    [No Abstract]   [Full Text] [Related]  

  • 16. The future of NSAID therapy: selective COX-2 inhibitors.
    Vane JR; Botting RM
    Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of COX-2].
    Tatsuguchi A; Sakamoto C
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():207-10. PubMed ID: 11979779
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of cyclooxygenase (COX) enzymes by compounds from Daucus carota L. Seeds.
    Momin RA; De Witt DL; Nair MG
    Phytother Res; 2003 Sep; 17(8):976-9. PubMed ID: 13680840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyclooxygenases, and the cell cycle. Their interactions in colon cancer.
    Rigas B; Shiff SJ
    Adv Exp Med Biol; 1999; 470():119-26. PubMed ID: 10709681
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?
    Warner TD; Mitchell JA
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13371-3. PubMed ID: 12374850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.